Valerie Odegard
CIK 1832432 · President and CSO · last filed 2026-05-11
Valerie Odegard is a President and CSO who has filed 4 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for ODTX, was dated May 11, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ODTX | Director | — | — | — | $0 | 1 | 2026-05-11 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | President and CSO | 61,639 | $5.87 | $361.8K | $0 | 3 | 2022-05-04 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | ODTX | Grant (A) | — | $0 | EDGAR |
| 2022-05-04 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | +45,233 | $0 | EDGAR |
| 2022-02-02 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | +16,406 | $0 | EDGAR |
| 2020-12-07 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | — | $0 | EDGAR |